Always Building Readiness:
A 2025 Reflection on Callan JMB’s Enduring Mission

Across every part of our organization, we built on the foundation established over nearly two decades, turning vision into execution and strategy into measurable progress.

This reflection captures the accomplishments that shaped 2025: our innovations in pharmaceutical infrastructure, our expansion into new sectors where compliance and sustainability matter, our deepening collaborations across the healthcare and wellness ecosystem, and the continued evolution of the systems and people who make readiness possible.

As we look toward 2026, we do so with momentum, clarity, and purpose. The achievements of this past year have not only strengthened our capabilities — they have positioned us for even greater impact as we continue building the infrastructure of resilience for the nation and the communities we serve.

From renewed public health challenges to global supply disruptions and extreme climate events, this year tested every assumption about readiness. And while much of the world reacted, Callan JMB was already executing.

For us, 2025 wasn’t about keeping pace with change — it was about leading it.

The events of 2025 reinforced what we’ve known for decades:readiness can’t depend on moments of crisis or waves of funding. It must be built into the nation’s daily operating fabric.

This year’s White House Executive Order to fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) made national headlines by calling for a six-month reserve of critical drug components.

At Callan JMB, this wasn’t a new direction — it was validation of the work we’ve been doing for years. From our leadership’s role in building the Strategic National Stockpile to our ongoing modernization of storage, tracking, and deployment systems, the infrastructure the nation now calls for already exists within our operations.

We’ve been building the future the policy envisions — brick by brick, system by system.

In May, we announced our strategic partnership with Revival Health, aligning two missions that share a single purpose:strengthening the infrastructure of health, wellness, and longevity in America.

Together, we’re building the systems that sustain not only medical readiness but human resilience — the ability for communities to thrive before, during, and after disruption. This partnership exemplifies our belief that preparedness isn’t a product — it’s a network.

From public health logistics to wellness infrastructure, Callan JMB and Revival Health are demonstrating that theprivate sector can operate with the same precision and purpose as national systems — and sometimes even faster.

2025 confirmed what Callan JMB has practiced for years:sustainability isn’t a corporate initiative; it’s an operational necessity. Every reusable container, every optimized route, every reduced waste cycle strengthens not just environmental outcomes, but national readiness.

Our closed-loop logistics model — refined and scaled this year — continues to show that what’s sustainable is also what’s most reliable. Resilience, efficiency, and stewardship are no longer competing priorities; they are mutually reinforcing. They’re the same mission.

But Callan JMB’s success has never been about any one individual.

It’s about the collective strength of a team that brings military precision, public health insight, engineering innovation, and logistical mastery together under one mission. From the planners who model readiness at the national level to the technicians who keep our systems running around the clock, every person at Callan JMB contributes to the same outcome: ensuring that when the nation calls, we are already ready.

Resilience isn’t just a product of leadership. It’s the result of a unified team — built for the mission, and committed to each other.

In 2025, information moved faster than ever — and so did the risks that come with it. That’s why we prioritized upgrading Sentry, our proprietary logistics and asset-tracking platform.

Sentry’s modernization reflects a larger principle that defines Callan JMB: Preparedness is not a state of being — it’s a system of knowing.

Just as importantly, this initiative marks a deliberate progression from our longstanding role in the storage and distribution of finished medical products into the sourcing and use of Active Pharmaceutical Ingredients (APIs) within new manufacturing processes. As global supply chains continue to shift, America’s ability to secure, transform, and deploy essential medicines becomes a strategic necessity.

This work does not stand alone. It is part of a broader set of initiatives underway with global healthcare leaders — including our partners at Revival Health — that share a unified purpose: building the infrastructure for a more resilient, self‑sufficient, and wellness‑focused future. Innovation is not simply a feature of readiness. It is the engine that allows readiness to evolve, adapt, and anticipate what comes next.

In 2025, our expansion into the food sampling sector underscored an essential truth: sustainability is no longer an initiative — it is an operational imperative.

The same pressures reshaping healthcare logistics are now transforming consumer markets. Food brands face rising expectations to reduce waste, verify sourcing, and ensure the integrity of every product placed in a consumer’s hands. Yet many sampling programs still lack standardized approaches to packaging, reclamation, or environmental accountability.

These gaps mirror the very challenges Callan JMB has solved for decades. By applying our compliance-driven, closed-loop logistics model to food sampling, we are helping brands replace disposable distribution practices with sustainable, measurable systems. From reclaiming unused inventory to reducing packaging waste to ensuring transparent traceability, our approach elevates sampling from a marketing activity to a responsible supply chain function.

Our collaboration with Keychain’s AI-powered manufacturing ecosystem further strengthens this mission. Together, we are enabling brands to understand the full lifecycle of their sampling programs — from production to shipment to reclamation — bringing the same rigor we apply in pharmaceuticals to a fast-growing consumer category.

Sustainability is not a separate priority from readiness. It is readiness. By reducing waste, increasing accountability, and building systems that conserve resources while protecting consumers, we reinforce the nation’s resilience across both regulated and emerging markets.

These aren’t new titles — they’re the foundation of who we’ve always been. Our mission has remained steady through decades of shifting priorities and emerging challenges: deliver reliability, design resilience, and drive results that last.

As we move into 2026, that same dependability continues to define us — proven in the field, trusted by our partners, and built for whatever comes next. Because preparedness isn’t a project, it’s a posture.